Literature DB >> 6832335

Platelet-activating factor effects on pulmonary ultrastructure in rabbits.

J C Lewis, J T O'Flaherty, C E McCall, R L Wykle, M G Bond.   

Abstract

Morphometric analysis of endothelium in rabbit lungs demonstrated a dramatic effect of platelet-activating factor (PAF) on the ultrastructure of pulmonary vasculature. Plasmalemmal vesicles in capillaries were increased both in size (638 A PAF vs 538 A control) and in number (386/micrograms 3 cytoplasm PAF vs 125/micrograms 3 cytoplasm control) when PAF was administered as a single acute low dose (chi less than 3 micrograms/kg). High concentrations of PAF (chi greater than 3 micrograms/kg) as a single acute dose also increased vesicle number (203/micrograms 3 cytoplasm), but frequently precipitated the respiratory distress syndrome. Chronic administration of PAF with daily doses over periods of either 3.5 or 7 weeks resulted in changes paralleling the acute observations, but did not lead to more extensive lung disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832335     DOI: 10.1016/0014-4800(83)90102-8

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion.

Authors:  M S Lewis; R E Whatley; P Cain; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 2.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

3.  Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.

Authors:  L M McManus; R N Pinckard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

4.  Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.

Authors:  J P Seale; S Nourshargh; P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome.

Authors:  Qing Chen; Ava Krol; Alex Wright; David Needham; Mark W Dewhirst; Fan Yuan
Journal:  Int J Hyperthermia       Date:  2008-09       Impact factor: 3.914

6.  Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.

Authors:  T W Evans; R J McAnulty; D F Rogers; K F Chung; P J Barnes; G J Laurent
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.